AtriCure Inc (NASDAQ: ATRC) stock closed at $36.70 on 11/28/23 after a major decline of -12.6%. The stock has declined -11.6% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, ATRC is expected to continue to be Value Creation neutral.
AtriCure has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. AtriCure has a very low Appreciation Score of 7 but a slightly positive Power Rating of 60, with the Negative Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment